Prokarium
Prokarium is a biopharmaceutical company focused on applying synthetic biology to develop cancer treatments. Their lead program is in clinical trials for bladder cancer, working on immunotherapies.
- Programmable therapeutics
- Oral immune training agent
- Therapeutic cargo delivery
- Microbial immunotherapy platform
Locations
Competitors
Intract Pharma is a biotechnology company focused on transforming patient care by developing oral drug delivery systems that replace injections with safer and more effective therapeutics.
Company Details
Prokarium is operated by Prokarium Limited and is a Active company incorporated on 3 July 2007 with the registered office located in London, Greater London. Prokarium Limited was registered 18 years ago.
Status
Active
Size
Micro
Directors
4
Age
18 years old
Employees
16
Turnover
£382K
Total Assets
£3.28M
Cash in Bank
£1.51M
Total Liabilities
-£49.28M
Teams
18
5
4
3
2
2
1
Chief Executive Officer • Joined Jul 2021
Executive Assistant To Chief Executive Officer • Joined Jun 2020
Non Executive Director • Joined May 2021
Principal Scientist • Joined Oct 2018
Principal Scientist • Joined Jan 2023
Chief Scientific Officer • Joined Nov 2021
Project Lead • Joined Aug 2023
Finance Manager • Joined Jun 2020
Project Manager
Head Of Quality • Joined Mar 2022
Principal Scientist • Joined Oct 2018
Principal Scientist • Joined Jan 2023
Chief Scientific Officer • Joined Nov 2021
Assay Development Scientist • Joined May 2023
VP Research • Joined Feb 2023
Project Lead • Joined Aug 2023
Head Of Quality • Joined Mar 2022
EA • Joined Jul 2023
Chief Executive Officer • Joined Jul 2021
Executive Assistant To Chief Executive Officer • Joined Jun 2020
Non Executive Director • Joined May 2021
Chief Scientific Officer • Joined Nov 2021
Analytical Consultant
HR Consultant • Joined Jul 2021
Finance Manager • Joined Jun 2020
Project Lead • Joined Aug 2023
Project Manager
View 18 members